ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

ClinicalTrials.gov ID: NCT02567409

Public ClinicalTrials.gov record NCT02567409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 12:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma

Study identification

NCT ID
NCT02567409
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
87 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2017
Primary completion
Apr 20, 2023
Completion
Apr 24, 2023
Last update posted
Mar 2, 2025

2017 – 2023

United States locations

U.S. sites
39
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054
Mayo Clinic in Arizona Scottsdale Arizona 85259
City of Hope Comprehensive Cancer Center Duarte California 91010
Los Angeles General Medical Center Los Angeles California 90033
USC / Norris Comprehensive Cancer Center Los Angeles California 90033
USC Norris Oncology/Hematology-Newport Beach Newport Beach California 92663
Stanford Cancer Institute Palo Alto Palo Alto California 94304
Keck Medical Center of USC Pasadena Pasadena California 91105
University of California Davis Comprehensive Cancer Center Sacramento California 95817
UCHealth University of Colorado Hospital Aurora Colorado 80045
Mayo Clinic in Florida Jacksonville Florida 32224-9980
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322
University of Kansas Clinical Research Center Fairway Kansas 66205
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
Brigham and Women's Hospital Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Dana-Farber Cancer Institute Boston Massachusetts 02215
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334
Mayo Clinic in Rochester Rochester Minnesota 55905
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141
Washington University School of Medicine St Louis Missouri 63110
Siteman Cancer Center-South County St Louis Missouri 63129
Siteman Cancer Center at Christian Hospital St Louis Missouri 63136
Nebraska Medicine-Bellevue Bellevue Nebraska 68123
Nebraska Medicine-Village Pointe Omaha Nebraska 68118
University of Nebraska Medical Center Omaha Nebraska 68198
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Case Western Reserve University Cleveland Ohio 44106
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232
Vanderbilt Breast Center at One Hundred Oaks Nashville Tennessee 37204
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232
University of Virginia Cancer Center Charlottesville Virginia 22908
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02567409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02567409 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →